Nippon Shinyaku Co., Ltd. and Janssen Pharmaceutical K.K. to Jointly Develop New Oral Immediately-Release Painkiller
24-Feb-2005 -
Nippon Shinyaku Co., Ltd., Janssen Pharmaceutical K.K. and Grunenthal GmbH have concluded a co-development agreement to jointly develop and commercialize in Japan an oral painkiller, Tramadol Hydrochloride Immediate-Release Formulation as of February 14, 2005.
Tramadol hydrochloride, a compound ...
cancer pain
Germany
Japan
+2